Aims: This document addresses the issue of whether older hypogonadal men will benefit from testosterone treatment and identifies the risks associated with such intervention. It is not intended to provide evidence for each recommendation as a review of pertinent studies was summarised by the Institute of Medicine (Washington 2004). The recommendations will be subject to revision as larger-scale and longer term data become available.